Vor Biopharma Inc. (VOR)
USD 0.66
(0.06%)
USD 0.66
(0.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 3.49 Million | 8.96 Million | 4.45 Million | 1.38 Million | 91 Thousand | 20 Thousand |
| Gross Profit | -3.49 Million | -8.96 Million | -4.45 Million | -1.38 Million | -91 Thousand | -20 Thousand |
| Operating Expenses | 126.03 Million | 93.41 Million | 69.01 Million | 43.36 Million | 10.41 Million | 2.86 Million |
| Selling, General and Administrative Expenses | 31.72 Million | 28.86 Million | 21.48 Million | 11.74 Million | 4.21 Million | 427 Thousand |
| Research and Development Expenses | 94.31 Million | 64.55 Million | 47.52 Million | 31.61 Million | 6.2 Million | 2.43 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 126.03 Million | 93.41 Million | 69.01 Million | 43.36 Million | 10.41 Million | 2.86 Million |
| Operating Income | -126.03 Million | -93.41 Million | -69.01 Million | -43.36 Million | -10.41 Million | -2.86 Million |
| Interest Expense | - | - | - | - | 608 Thousand | 1 Million |
| Income Tax Expense | - | -1.32 Million | -119 Thousand | 427.7 Thousand | 608 Thousand | -289 Thousand |
| Earnings before Tax | -117.86 Million | -92.09 Million | -68.89 Million | -43.33 Million | -10.83 Million | -4.15 Million |
| Net Income | -117.86 Million | -90.77 Million | -68.78 Million | -43.33 Million | -11.44 Million | -4.15 Million |
| Earnings Per Share Basic | -1.75 | -2.29 | -1.85 | -1.17 | -0.31 | -0.73 |
| Earnings Per Share Diluted | -1.75 | -2.29 | -1.85 | -1.17 | -0.31 | -0.73 |
| Weighted Average Shares Outstanding | 67.19 Million | 39.55 Million | 37.17 Million | 37.12 Million | 37.12 Million | 5.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 67.19 Million | 39.55 Million | 37.17 Million | 37.12 Million | 37.12 Million | 5.66 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -114.37 Million | -90.89 Million | -67.58 Million | -41.95 Million | -10.17 Million | -2.84 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 12.22 Million | - | - |
| Cost of Revenue | 900 Thousand | 943 Thousand | 3.49 Million | 892 Thousand | 2.08 Million | 1.23 Million |
| Gross Profit | -900 Thousand | -943 Thousand | -3.49 Million | 11.33 Million | -2.08 Million | -1.23 Million |
| Operating Expenses | 28.13 Million | 31.38 Million | 122.54 Million | 27.23 Million | 35.31 Million | 32.17 Million |
| Selling, General and Administrative Expenses | 6.31 Million | 7.06 Million | - | 6.33 Million | 7.71 Million | 8.27 Million |
| Research and Development Expenses | 21.82 Million | 24.32 Million | - | 20.89 Million | 27.6 Million | 23.89 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 29.03 Million | 32.32 Million | 126.03 Million | 28.12 Million | 35.31 Million | 32.17 Million |
| Operating Income | -29.03 Million | -32.32 Million | -126.03 Million | -28.12 Million | -35.31 Million | -32.17 Million |
| Interest Expense | - | - | - | 1.98 Million | - | - |
| Income Tax Expense | - | 899.72 Thousand | - | 565 Thousand | 1.42 Million | 3.06 Million |
| Earnings before Tax | -27.83 Million | -30.8 Million | -117.86 Million | -26.26 Million | -33.19 Million | -29.97 Million |
| Net Income | -27.83 Million | -30.8 Million | -117.86 Million | -26.26 Million | -33.19 Million | -29.97 Million |
| Earnings Per Share Basic | -0.41 | -0.45 | - | -0.39 | -0.49 | -0.45 |
| Earnings Per Share Diluted | -0.41 | -0.45 | - | -0.39 | -0.49 | -0.45 |
| Weighted Average Shares Outstanding | 68.29 Million | 68.03 Million | 67.19 Million | 67.89 Million | 67.6 Million | 67.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 68.29 Million | 68.03 Million | 67.19 Million | 67.89 Million | 67.6 Million | 67.03 Million |
| Gross Margin | - | - | - | 0.93 | - | - |
| EBIT Margin | - | - | - | -2.23 | - | - |
| Profit Margin | - | - | - | -2.15 | - | - |
| EBITDA | -28.13 Million | -31.38 Million | - | -27.23 Million | -35.31 Million | -28.98 Million |
| Earnings Before Tax Margin | - | - | - | -2.30 | - | - |
080160
LIPI
9521
8010
ATS
JBMA